Monoferric prescribing information. Pharmacosmos Therapeutics Inc. Morristown, NJ 2024. G. Injectafer prescribing information. American Regent, Inc. Shirley
Feraheme [prescribing information]. Waltham, MA: AMAG Pharmaceuticals, Inc.; June 2024. 2. Injectafer [prescribing information]. Shirley, NY: American
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Injectafer safely and effectively. See full prescribing information for Injectafer. INJECTAFER (ferric carboxymaltose injection), for intravenous use Initial U.S. Approval: 2024
More about Injectafer (ferric carboxymaltose) Check interactions; Compare alternatives; Pricing coupons; Reviews (8) Side effects; Dosage information; Patient tips; During pregnancy; FDA approval history; Drug class: iron products; Breastfeeding; Patient resources. Injectafer drug information; Professional resources. Injectafer prescribing
Injectafer (ferric carboxymaltose injection) is indicated for Monoferric [prescribing information]. Morristown (NJ): Pharmacosmos
Note that this list is not all-inclusive and includes only common medications that may interact with Injectafer. You should refer to the prescribing information for Injectafer for a complete list of interactions.
The majority of patients (93 to 95 percent) in trials of Injectafer received the target dose of 1500 mg. The full prescribing information for Injectafer is
Injectafer, an iron replacement product, is indicated for Injectafer intravenous infusion or slow injection [prescribing information].
Injectafer safely and effectively. See full prescribing information for Injectafer. INJECTAFER (ferric carboxymaltose injection), for intravenous use Initial U.S. Approval: 2024 -INDICATIONS AND USAGE-Injectafer is an iron replacement product indicated for the treatment of iron
Comments
SHOULD BE:
Andy had literally simply RELAYED all the various information.